Skip to content
Healthtech

Technical Due Diligence for Healthtech businesses

Healthtech balances clinical rigour, privacy law and the pressure to actually improve care. That is exactly where technical due diligence earn their keep — independent technical assessments for investors, boards and acquirers — covering codebase, architecture, security, scalability and team — delivered as a clear, decision-ready report.

Pressures in Healthtech

What healthtech businesses are up against

  • strict privacy and data-handling requirements.
  • integration with legacy clinical and practice-management systems.
  • the burden of proving safety and reliability.

What changes

How Technical Due Diligence helps

  • A clear-eyed view of technical risk before you commit
  • Confidence in scalability and security claims
  • An honest read on the engineering team
  • A remediation roadmap if you proceed

Scope

Technical Due Diligence, delivered for Healthtech

Independent technical assessments for investors, boards and acquirers — covering codebase, architecture, security, scalability and team — delivered as a clear, decision-ready report.

01

Codebase & architecture review

02

Security & compliance assessment

03

Scalability & infrastructure analysis

04

Team, process & delivery evaluation

05

Risk register & remediation roadmap

FAQ

Technical Due Diligence for Healthtech — questions

Why does Healthtech need technical due diligence?
Healthtech balances clinical rigour, privacy law and the pressure to actually improve care. Technical Due Diligence directly addresses that: a clear-eyed view of technical risk before you commit, and confidence in scalability and security claims.
How long does technical due diligence take?
Most engagements run one to three weeks depending on scope and deal timeline. A focused red-flag review can be delivered in days when speed matters.
What do we receive at the end?
A decision-ready report: an executive summary, a scored risk register, and a prioritised remediation roadmap — written to be read by both investors and engineers.

Ready to talk technical dd for your healthtech business?

A free, no-obligation conversation with Vinnie Amir about what would move the needle.